Differential protein biomarker expression and their time-course in patients with a spectrum of stable and unstable coronary syndromes in the Integrated Biomarker and Imaging Study-1 (IBIS-1)

International Journal of Cardiology

Volumn 149, Issue 1, 2011, Pages 10-16

  Wykrzykowska, Joanna J ^a   Garcia Garcia, Hector M ^a   Goedhart, Dick ^a   Zalewski, Andrew ^a   Serruys, Patrick W ^a  

^a NONE

Author keywords

Biomarkers; Intravascular ultrasound; Palpography; Plaque imaging; Proteomics; Vulnerable plaque

Indexed keywords

CUTANEOUS T CELL ATTRACTING CHEMOKINE; D DIMER; FOLLISTATIN; KERATINOCYTE GROWTH FACTOR; SCATTER FACTOR; THROMBOCYTE FACTOR 4;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; CARDIAC IMAGING; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PATIENT IDENTIFICATION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CARDIAC IMAGING TECHNIQUES; CORONARY ARTERY DISEASE; DIAGNOSIS, DIFFERENTIAL; HEART DISEASES; HUMANS; MYOCARDIAL INFARCTION; PILOT PROJECTS; PROTEOMICS; RISK FACTORS; TIME FACTORS;

EID: 79955936194     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.11.033     Document Type: Article

References (21)

1. Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol 2001;88(7B):3J-6J.
2. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109(21 Suppl 1):II2-II10.
3. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20(5):1262-75. (Pubitemid 30262927)
4. Aoki J, Abizaid AC, Serruys PW, et al. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 2005;46(9):1670-6. (Pubitemid 41531621)
5. Schaar JA, De Korte CL, Mastik F, et al. Characterizing vulnerable plaque features with intravascular elastography. Circulation 2003;108(21):2636-41. (Pubitemid 37466804)
6. Mollet NR, Cademartiri F, van Mieghem CA, et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation 2005;112(15):2318-23. (Pubitemid 41464575)
7. Van Mieghem CA, McFadden EP, de Feyter PJ, et al. Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS). J Am Coll Cardiol 2006;47(6):1134-42.
8. Schweitzer B, Roberts S, Grimwade B, Shao W, Wang M, Fu Q, et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol 2002;20(4):359-65. (Pubitemid 34288474)
9. Van Mieghem CA, Bruining N, Schaar JA, McFadden E, Mollet N, Cademartiri F, et al. Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology. Int J Cardiovasc Imaging 2005;21(4):425-41. (Pubitemid 41136095)
10. de Maat MP, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Moller L, Jespersen J. Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost 2003;1(5):950-7.
11. von Hundelshausen P, Koenen RR, Sack M, et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2005;105(3):924-30. (Pubitemid 40170856)
12. Hata N, Matsumori A, Yokoyama S, et al. Hepatocyte growth factor and cardiovascular thrombosis in patients admitted to the intensive care unit. Circ J 2004;68(7):645-9. (Pubitemid 38899598)
13. Liu Y, Wilkinson FL, Kirton JP, et al. Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. J Pathol 2007;212(1):12-9. (Pubitemid 46746285)
14. Tillmanns J, Rota M, Hosoda T, et al. Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci U S A 2008;105(5):1668-73. (Pubitemid 351346572)
15. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007;100(1):27-40. (Pubitemid 46066771)
16. Smith C, Yndestad A, Halvorsen B, et al. Potential anti-inflammatory role of activin A in acute coronary syndromes. J Am Coll Cardiol 2004;44(2):369-75. (Pubitemid 38950596)
17. Chang K, Weiss D, Suo J, et al. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation 2007;116(11):1258-66. (Pubitemid 47517537)
18. Haque NS, Zhang X, French DL, et al. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 2000;102(7):786-92. (Pubitemid 30643286)
19. Haque NS, Fallon JT, Pan JJ, Taubman MB, Harpel PC. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood 2004;103(4):1296-304. (Pubitemid 38168640)
20. Ky B, Burke A, Tsimikas S, et al. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. J Am Coll Cardiol 2008;51(17):1653-62. (Pubitemid 351626406)
21. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131(2):149-50.